Markwin Velders

Markwin Velders is an accomplished professional in the life sciences sector, currently serving as the Managing Director and Owner of Prime Life Science since January 2020, focusing on interim management and consultancy aimed at technology startups. Velders holds key supervisory and advisory roles at several organizations, including Amarna Therapeutics B.V., ISA Pharmaceuticals, and NECSTGEN. With experience as VP of Operations at Kite Pharma and CEO of SomantiX B.V., Velders has a strong background in biopharmaceuticals and immunotherapy. Educational accomplishments include a PhD in Molecular Immunology and a Master of Science in Biomedical Sciences from Leiden University, alongside specialized training at the Weizmann Institute of Science.